Business Insights: The Private Health Insurance Market in Europe

There are over 84 million Europeans with some form of private health insurance. Germans account for the largest proportion of the privately insured population, with 22.3 million, followed by the Dutch with 16.2 million – Business Insights, 2010.

The dynamics of healthcare funding in Europe is changing. As governments review their options to meet growing healthcare demands with limited resources, the potential to combine cost reduction with new funding sources will gain support in many countries. Reimbursement decisions in the public sector are becoming increasingly tougher for pharmaceutical and diagnostic manufacturers; the private market offers a potential alternative route to gaining market access.

Private insurers currently play differing roles in European national healthcare systems. This report reviews their role in the major European markets and provides an insight into trends in their coverage of health benefits and products. It highlights selected product areas where private insurance could fill the gaps in public reimbursement. An insight into the European private insurance industry, including overall trends and profiles of leading insurers, provides an indication of future developments within the sector and highlights potential opportunities for pharmaceutical and diagnostic companies to work with private insurers.

Click here to view a sample of this report.

This report helps

• Understand the diverse roles played by private insurance in funding pharmaceutical and diagnostic products in major European markets and the relative importance of private funds in healthcare spending.
• Identify the key players in each market who will be potential targets for gaining market access in the privately-funded sector.
• Review what new opportunities might be afforded in the private sector for products that are denied reimbursement in the public sector.
• Tailor product portfolios to meet differing needs of individual markets.

This report answers the following questions?

• How many Europeans have private health insurance and why do they purchase private cover?
• What proportion of healthcare costs are paid for by private insurers in the major European markets?
• How influenced are private insurers by public health pharmaceutical reimbursement decisions?
• Who are the major movers and shakers in the European private health insurance market? 
• What initiatives are underway by insurers to cover pharmaceutical products not reimbursed by national healthcare systems?
• What role do private insurers play in public-private partnerships?

Click here to view a sample of this report.

The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/437-4276 or e-mail account manager Maureen Croce at mcroce@hcpro.com.

• Reports

• Other Life Sciences Products